At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations

Trials
Jane SmithARRISA-UK Group

Abstract

Despite effective treatments and long-standing management guidelines, there are approximately 1400 hospital admissions for asthma weekly in the United Kingdom (UK), many of which could be avoided. In our previous research, a secondary analysis of the intervention (ARRISA) suggested an improvement in the management of at-risk asthma patients in primary care. ARRISA involved identifying individuals at risk of adverse asthma events, flagging their electronic health records, training practice staff to develop and implement practice-wide processes of care when alerted by the flag, plus motivational reminders. We now seek to determine the effectiveness and cost-effectiveness of ARRISA in reducing asthma-related crisis events. We are undertaking a pragmatic, two-arm, multicentre, cluster randomised controlled trial, plus health economic and process evaluation. We will randomise 270 primary care practices from throughout the UK covering over 10,000 registered patients with 'at-risk asthma' identified according to a validated algorithm. Staff in practices randomised to the intervention will complete two 45-min eLearning modules (an individually completed module giving background to ARRISA and a group-completed module to develop practice...Continue Reading

References

Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·A E TattersfieldA Ullman
May 6, 2004·Health Economics·Elisabeth FenwickAndrew Briggs
Aug 2, 2005·Thorax·P M SturdyUNKNOWN National Asthma Campaign Mortality and Severe Morbidity Group
May 17, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Michael J NobleJennifer Windley
Jun 19, 2009·American Journal of Respiratory and Critical Care Medicine·Helen K ReddelUNKNOWN American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations
Aug 1, 2009·American Journal of Respiratory and Critical Care Medicine·Jacqueline GambleLiam G Heaney
Feb 2, 2010·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Hilary PinnockBronwen Wagstaff
Aug 2, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Stanley J SzeflerBradley E Chipps
Feb 14, 2012·The Journal of Allergy and Clinical Immunology·Jasmina I IvanovaKimmie McLaurin
Jul 4, 2012·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Hilary PinnockDavid Price
Mar 21, 2015·BMJ : British Medical Journal·Graham F MooreJanis Baird
Jun 22, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Robert FleetcroftNicholas Steel
Mar 18, 2017·BMC Medicine·Hilary PinnockUNKNOWN PRISMS and RECURSIVE groups

❮ Previous
Next ❯

Citations

Mar 7, 2020·Pediatric Pulmonology·Stanley J SzeflerWarren Lenney
Jun 20, 2020·NPJ Primary Care Respiratory Medicine·Monica J FletcherThys van der Molen
Jun 17, 2021·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Michael NobleAndrew M Wilson

❮ Previous
Next ❯

Methods Mentioned

BETA
RSA

Clinical Trials Mentioned

ISRCTN95472706

Software Mentioned

SystmOne
AUKCAR
Framework Analysis
EMIS
ARRISA
Vision
NVivo
Structured Query Language ( SQL ) Server

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.